LEARN MORE

Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.

LEARN MORE

Events

Cantor Fitzgerald's Global Healthcare Conference

9/25/17 - 9/27/17

More Events >

Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

PostpartumSupportInt's Twitter avatar
PostpartumSupportInt
@PostpartumHelp

Woman reveals the side-effect of giving birth that nobody talks about t.co/tJEZNEHr5u via @Independent

Retweeted by Marinus Pharma